Development of hematologic toxicity with sequential treatment of Y90 followed by PRRT in five patients at single institution with metastatic neuroendocrine patients. This is an ASCO Meeting Abstract ...
Comparisons of survival outcomes of antibody-drug-conjugates in metastatic breast cancer: A network meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results